2A Pharma ApS: Financial statements 2018
CVR: 39391597
Source: annual report 2018, Danish Business Authority
01/03/2018 – 31/12/2018
2A Pharma ApS (CVR 39391597) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 947,126 and a net result of DKK -59,940. Equity in the 2018 report amounted to DKK 425,740. The solvency ratio was 76.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 947,126
- Profit/Loss
- DKK -59,940
- Equity
- DKK 425,740
- Total Assets
- DKK 559,196
- Employees
- 1
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of March 1, 2018, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of 2A Pharma ApS.
As of March 1, 2018, Preben Bruun-Nyzell is registered as director of 2A Pharma ApS.
As of March 1, 2018, Sigbjørn Georg Nielsen Kjærgård is registered as adm. dir. of 2A Pharma ApS.
As of March 1, 2018, Josephus Dirk Vestergaard Nieland is registered as director of 2A Pharma ApS.
As of March 1, 2018, is registered as an owner of 2A Pharma ApS with an ownership share of 100%.
2A Pharma ApS was founded on February 27, 2018.
About 2A Pharma ApS
2A Pharma ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Preben Bruun-Nyzell and Josephus Dirk Vestergaard Nieland. The company is owned by 2A Pharma AB. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 587,253 and a net result of DKK -712,675 compared with DKK 4,297 the year before. Equity in the 2025 report amounted to DKK 263,490.